nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—Pethidine—GRIN2B—Parkinson's disease	0.0155	0.15	CrCbGaD
Cyclopentolate—Methylphenidate—SLC6A3—Parkinson's disease	0.0145	0.14	CrCbGaD
Cyclopentolate—Dexmethylphenidate—SLC6A3—Parkinson's disease	0.0145	0.14	CrCbGaD
Cyclopentolate—Venlafaxine—SLC6A3—Parkinson's disease	0.0143	0.139	CrCbGaD
Cyclopentolate—Dexmethylphenidate—CYP2D6—Parkinson's disease	0.0076	0.0738	CrCbGaD
Cyclopentolate—Methylphenidate—CYP2D6—Parkinson's disease	0.0076	0.0738	CrCbGaD
Cyclopentolate—Venlafaxine—CYP2D6—Parkinson's disease	0.00751	0.0729	CrCbGaD
Cyclopentolate—Pethidine—SLC6A3—Parkinson's disease	0.00732	0.071	CrCbGaD
Cyclopentolate—Venlafaxine—ABCB1—Parkinson's disease	0.00536	0.0521	CrCbGaD
Cyclopentolate—Pethidine—CYP2D6—Parkinson's disease	0.00384	0.0373	CrCbGaD
Cyclopentolate—Orphenadrine—CYP2E1—Parkinson's disease	0.00286	0.0277	CrCbGaD
Cyclopentolate—Diphenhydramine—CYP2D6—Parkinson's disease	0.00222	0.0215	CrCbGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00176	0.00196	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00175	0.00195	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ND3—Parkinson's disease	0.00174	0.00195	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—MCCC1—Parkinson's disease	0.00174	0.00195	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00173	0.00193	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00173	0.00193	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00173	0.00193	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00173	0.00193	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00173	0.00193	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00172	0.00192	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—GPR37—Parkinson's disease	0.0017	0.00189	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—DGKQ—Parkinson's disease	0.0017	0.00189	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.0017	0.00189	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—GPR37—Parkinson's disease	0.00169	0.00189	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—DGKQ—Parkinson's disease	0.00169	0.00189	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00169	0.00189	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00164	0.00183	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—TALDO1—Parkinson's disease	0.00164	0.00183	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—OMD—Parkinson's disease	0.00164	0.00183	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00164	0.00183	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00161	0.00179	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.0016	0.00179	CbGpPWpGaD
Cyclopentolate—CHRM1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00157	0.00175	CbGpPWpGaD
Cyclopentolate—CHRM3—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00157	0.00175	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—NDUFB11—Parkinson's disease	0.00156	0.00173	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—RPL14—Parkinson's disease	0.00155	0.00173	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—RPL23A—Parkinson's disease	0.00155	0.00173	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00155	0.00173	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00155	0.00173	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00154	0.00172	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00154	0.00171	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00149	0.00166	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00149	0.00166	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GCH1—Parkinson's disease	0.00148	0.00165	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00148	0.00165	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00148	0.00165	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—RPS8—Parkinson's disease	0.00145	0.00162	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.00142	0.00158	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—GRK5—Parkinson's disease	0.00141	0.00157	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00141	0.00157	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.0014	0.00156	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MCCC1—Parkinson's disease	0.00134	0.0015	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ND3—Parkinson's disease	0.00134	0.0015	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00134	0.00149	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00134	0.00149	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—HTR1A—Parkinson's disease	0.00133	0.00149	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GBA—Parkinson's disease	0.00132	0.00147	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—FBP1—Parkinson's disease	0.00132	0.00147	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—DBH—Parkinson's disease	0.00132	0.00147	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.00132	0.00147	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—TAC1—Parkinson's disease	0.00131	0.00146	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.00129	0.00144	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—DRD1—Parkinson's disease	0.00129	0.00144	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.00129	0.00143	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—GRK5—Parkinson's disease	0.00128	0.00143	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00127	0.00142	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—GRM4—Parkinson's disease	0.00127	0.00141	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—OMD—Parkinson's disease	0.00126	0.00141	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TALDO1—Parkinson's disease	0.00126	0.00141	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.00125	0.00139	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—DRD3—Parkinson's disease	0.00125	0.00139	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00121	0.00135	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00121	0.00135	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VPS35—Parkinson's disease	0.00121	0.00135	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VPS35—Parkinson's disease	0.00121	0.00135	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.0012	0.00134	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PENK—Parkinson's disease	0.0012	0.00134	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—NDUFB11—Parkinson's disease	0.0012	0.00133	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00119	0.00133	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00119	0.00132	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.00115	0.00129	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—GRM4—Parkinson's disease	0.00115	0.00128	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GCH1—Parkinson's disease	0.00114	0.00127	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.00113	0.00126	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.00113	0.00126	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—HTR7—Parkinson's disease	0.00113	0.00126	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—DRD2—Parkinson's disease	0.00113	0.00126	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.0011	0.00123	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PDYN—Parkinson's disease	0.0011	0.00122	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PENK—Parkinson's disease	0.00109	0.00122	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PENK—Parkinson's disease	0.00109	0.00122	CbGpPWpGaD
Cyclopentolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00104	0.00116	CbGpPWpGaD
Cyclopentolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00104	0.00116	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00102	0.00114	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—GRM5—Parkinson's disease	0.00102	0.00114	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—DBH—Parkinson's disease	0.00102	0.00113	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—FBP1—Parkinson's disease	0.00102	0.00113	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GBA—Parkinson's disease	0.00102	0.00113	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.001	0.00112	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GPR37—Parkinson's disease	0.001	0.00112	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.001	0.00112	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DGKQ—Parkinson's disease	0.001	0.00111	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GPR37—Parkinson's disease	0.001	0.00111	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PDYN—Parkinson's disease	0.000998	0.00111	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—DDC—Parkinson's disease	0.00097	0.00108	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.00093	0.00104	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—GRM5—Parkinson's disease	0.000927	0.00103	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000917	0.00102	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GSTA4—Parkinson's disease	0.000916	0.00102	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000914	0.00102	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.000906	0.00101	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000905	0.00101	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—EDN1—Parkinson's disease	0.000903	0.00101	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000871	0.000971	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000868	0.000968	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—IGF2—Parkinson's disease	0.000865	0.000964	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PLA2G6—Parkinson's disease	0.000825	0.00092	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—MAOB—Parkinson's disease	0.000817	0.000911	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.000806	0.000899	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	0.000802	0.000894	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RIT2—Parkinson's disease	0.000799	0.000891	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.000792	0.000883	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000791	0.000882	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—HTR2A—Parkinson's disease	0.00079	0.000881	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000789	0.000879	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000777	0.000867	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.00076	0.000847	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	0.000758	0.000845	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000756	0.000843	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000753	0.00084	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—DDC—Parkinson's disease	0.000746	0.000832	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.000744	0.00083	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	0.000742	0.000827	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00073	0.000814	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	0.000728	0.000811	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.000707	0.000788	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	0.000705	0.000786	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTA4—Parkinson's disease	0.000705	0.000786	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.000686	0.000765	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	0.000684	0.000763	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.000682	0.00076	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	0.00068	0.000758	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.000676	0.000754	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	0.000674	0.000751	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.000663	0.000739	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	0.000661	0.000737	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00066	0.000736	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.000658	0.000734	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.000646	0.000721	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.000646	0.000721	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAG—Parkinson's disease	0.000644	0.000718	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PENK—Parkinson's disease	0.000644	0.000718	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000642	0.000716	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	0.00064	0.000713	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000639	0.000713	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000639	0.000713	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000637	0.000711	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000637	0.000711	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PLA2G6—Parkinson's disease	0.000635	0.000707	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MAOB—Parkinson's disease	0.000628	0.0007	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CYP2D6—Parkinson's disease	0.000607	0.000677	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.0006	0.000668	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000598	0.000666	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CTGF—Parkinson's disease	0.000596	0.000664	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000591	0.000659	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	0.000589	0.000657	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.000581	0.000647	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.000581	0.000647	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	0.000579	0.000645	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	0.000579	0.000645	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—INS—Parkinson's disease	0.000574	0.00064	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000556	0.00062	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CYP2E1—Parkinson's disease	0.000555	0.000619	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	0.000554	0.000618	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.00055	0.000613	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—NQO1—Parkinson's disease	0.000549	0.000612	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	0.000548	0.000611	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—TH—Parkinson's disease	0.000541	0.000603	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CYCS—Parkinson's disease	0.00052	0.000579	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000515	0.000574	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000512	0.000571	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	0.00051	0.000569	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000488	0.000544	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000486	0.000542	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000482	0.000537	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	0.00048	0.000536	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000467	0.000521	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP2D6—Parkinson's disease	0.000467	0.00052	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000466	0.000519	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000465	0.000518	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	0.000463	0.000517	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—COMT—Parkinson's disease	0.00046	0.000513	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CTGF—Parkinson's disease	0.000458	0.000511	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GSTP1—Parkinson's disease	0.000458	0.000511	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—MAOA—Parkinson's disease	0.000457	0.000509	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—HMOX1—Parkinson's disease	0.000452	0.000503	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000448	0.000499	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000446	0.000498	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ABCB1—Parkinson's disease	0.000433	0.000483	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.000431	0.000481	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—INSR—Parkinson's disease	0.00043	0.000479	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP2E1—Parkinson's disease	0.000427	0.000476	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—NQO1—Parkinson's disease	0.000422	0.000471	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GSTM1—Parkinson's disease	0.000421	0.000469	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TH—Parkinson's disease	0.000416	0.000464	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000408	0.000454	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000407	0.000453	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGB—Parkinson's disease	0.000406	0.000453	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000405	0.000452	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000405	0.000452	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	0.000404	0.000451	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GPX1—Parkinson's disease	0.000403	0.000449	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYCS—Parkinson's disease	0.0004	0.000445	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000399	0.000445	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	0.000398	0.000444	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000392	0.000437	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	0.00039	0.000435	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000379	0.000423	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	0.000378	0.000421	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—MTHFR—Parkinson's disease	0.000372	0.000415	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000354	0.000395	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—COMT—Parkinson's disease	0.000354	0.000394	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000353	0.000394	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTP1—Parkinson's disease	0.000352	0.000393	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MAOA—Parkinson's disease	0.000351	0.000392	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—HMOX1—Parkinson's disease	0.000347	0.000387	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOE—Parkinson's disease	0.000346	0.000386	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000343	0.000382	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000343	0.000382	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	0.000342	0.000381	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	0.000342	0.000381	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ABCB1—Parkinson's disease	0.000333	0.000372	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTM1—Parkinson's disease	0.000324	0.000361	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GPX1—Parkinson's disease	0.00031	0.000345	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—INS—Parkinson's disease	0.000296	0.00033	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000287	0.00032	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	0.000287	0.000319	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—MTHFR—Parkinson's disease	0.000286	0.000319	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000278	0.00031	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	0.000277	0.000309	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000275	0.000306	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	0.000274	0.000305	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOE—Parkinson's disease	0.000266	0.000297	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.000252	0.000281	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NGF—Parkinson's disease	0.000252	0.00028	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.00024	0.000268	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	0.000239	0.000267	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—INS—Parkinson's disease	0.000227	0.000254	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOE—Parkinson's disease	0.000223	0.000249	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOE—Parkinson's disease	0.000223	0.000248	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—INS—Parkinson's disease	0.000191	0.000213	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—INS—Parkinson's disease	0.00019	0.000212	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	0.000142	0.000158	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	0.000142	0.000158	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000141	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	0.000141	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	0.000131	0.000146	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	0.00013	0.000145	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6—Parkinson's disease	8.34e-05	9.29e-05	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6—Parkinson's disease	8.31e-05	9.26e-05	CbGpPWpGaD
